Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis

被引:22
|
作者
Budhram, Dalton R. [1 ]
Mac, Stephen [2 ,3 ]
Bielecki, Joanna M. [3 ]
Patel, Samir N. [4 ,5 ]
Sander, Beate [2 ,3 ,4 ,6 ]
机构
[1] Queens Univ, Dept Med, Kingston, ON, Canada
[2] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada
[4] Publ Hlth Ontario, Publ Hlth Ontario Lab, 661 Univ Ave, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Inst Clin Evaluat Sci, Toronto, ON, Canada
关键词
CARE-UNIT PATIENTS; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; RESISTANT ENTEROBACTERIACEAE; BETA-LACTAMASE; MORTALITY; IMPACT; COLONIZATION;
D O I
10.1017/ice.2019.282
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Carbapenemase-producing Enterobacteriaceae (CPE) pose a significant global health threat. Objective: To conduct a systematic review of health outcomes and long-term sequelae attributable to CPE infection. Methods: We followed PRISMA reporting guidelines and published our review protocol on PROSPERO (CRD42018097357). We searched Medline, Embase, CINAHL and the Cochrane Library. We included primary studies with a carbapenem-susceptible control group in high-income countries, published in English. Quality appraisal was completed using Joanna Briggs Institute checklists. We qualitatively summarized frequently reported outcomes and conducted a meta-analysis. Results: Our systematic review identified 8,671 studies; 17 met the eligibility criteria for inclusion. All studies reported health outcomes; none reported health-related quality-of-life. Most studies were from Europe (65%), were conducted in teaching or university-affiliated hospitals (76%), and used case-control designs (53%). Mortality was the most commonly reported consequence of CPE-infections; in-hospital mortality was most often reported (62%). Our meta-analysis (n = 5 studies) estimated an absolute risk difference (ARD) for in-hospital bloodstream infection mortality of 0.25 (95% confidence interval [CI], 0.17-0.32). Duration of antibiotic therapy (range, 4-29.7 vs 1-23.6 days) and length of hospital stay (range, 21-87 vs 15-43 days) were relatively higher for CPE-infected patients than for patients infected with carbapenem-susceptible pathogens. Most studies (82%) met >80% of their respective quality appraisal criteria. Conclusions: The risk of in-hospital mortality due to CPE bloodstream infection is considerably greater than carbapenem-susceptible bloodstream infection (ARD, 0.25; 95% CI, 0.17-0.32). Health outcome studies associated with CPE infection are focused on short-term (eg, in-hospital) outcomes; long-term sequelae and quality-of-life are not well studied.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [41] Conceptual framework of antibiotic stewardship programs in reducing ESBL-producing Enterobacteriaceae: a systematic review and meta-analysis
    Keikha, Masoud
    Kamali, Hossein
    Ghazvini, Kiarash
    Karbalaei, Mohsen
    JOURNAL OF CHEMOTHERAPY, 2022, 34 (08) : 483 - 491
  • [42] Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis
    Martin, Amber
    Fahrbach, Kyle
    Zhao, Qi
    Lodise, Thomas
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (07):
  • [43] Association between carbapenem-resistant Enterobacteriaceae and death: A systematic review and meta-analysis
    Soontaros, Suluck
    Leelakanok, Nattawut
    AMERICAN JOURNAL OF INFECTION CONTROL, 2019, 47 (10) : 1200 - 1212
  • [44] Clinical characteristics and treatment of IMP-type carbapenemase-producing Enterobacteriaceae bacteremia: Case series and literature review
    Soneda, Keiko
    Uda, Kazuhiro
    Araki, Kotaro
    Murakoshi, Takatsugu
    Yuza, Yuki
    Saito, Osamu
    Kinoshita, Kazue
    Higuchi, Hiroshi
    Horikoshi, Yuho
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (01) : 26 - 32
  • [45] A Retrospective Study of Risk Factors, Mortality, and Treatment Outcomes for Infections with Carbapenemase-Producing Enterobacterales in a Tertiary Hospital in Havana, Cuba
    Yu, Haiyang
    Hernandez Gonzalez, Alberto
    Estevez Torres, Gonzalo
    Gonzalez Molina, Maria Karla
    Hart Casares, Marcia
    Han, Xu
    Baldoquin Rodriguez, Waldemar
    Quinones Perez, Dianelys
    ANTIBIOTICS-BASEL, 2022, 11 (07):
  • [46] Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
    Vardakas, Konstantinos Z.
    Tansarli, Giannoula S.
    Rafailidis, Petros I.
    Falagas, Matthew E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (12) : 2793 - 2803
  • [47] Carbapenemase-Producing Non-Glucose-Fermenting Gram-Negative Bacilli in Africa, Pseudomonas aeruginosa and Acinetobacter baumannii: A Systematic Review and Meta-Analysis
    Kindu, Mizan
    Derseh, Lemma
    Gelaw, Baye
    Moges, Feleke
    INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2020, 2020
  • [48] Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam
    De la Calle, Cristina
    Rodriguez, Olga
    Morata, Laura
    Marco, Francesc
    Cardozo, Celia
    Garcia-Vidal, Carolina
    Del Rio, Ana
    Feher, Csaba
    Pellice, Martina
    Puerta-Alcalde, Pedro
    Mensa, Josep
    Soriano, Alex
    Antonio Martinez, Jose
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (04) : 520 - 524
  • [49] Successful treatment of invasive carbapenemase-producing Enterobacteriaceae infections in children using carbapenem-aminoglycoside combination therapy: A case series
    Williams, Phoebe C. M.
    Bartlett, Adam W.
    Palasanthiran, Pamela
    Armstrong, Benjamin
    McMullan, Brendan J.
    INFECTION DISEASE & HEALTH, 2020, 25 (04) : 314 - 318
  • [50] Coronary Stent Infections - A Systematic Review and Meta-Analysis
    Ramakumar, Venkatakrishnan
    Thakur, Abhishek
    Abdulkader, Rizwan Suliankatchi
    Claessen, Bimmer
    Anandaram, Asuwin
    Palraj, Raj
    Aravamudan, Veeraraghavan Meyyur
    Ramamurthy, Muralidharan Thoddi
    Dangas, George
    Senguttuvan, Nagendra Boopathy
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 54 : 16 - 24